Our Technology
The SynerFuse® e-TLIF™ procedure incorporates input from the company’s medical team of surgeons and learnings from our completed proof-of-concept (POC) study. This enables our NeuroFuse® System provide Ultra Low Energy (ULE) therapy for direct nerve stimulation at the point of spine fusion. The NeuroFuse® System consists of an implantable pulse generator (“IPG”), a multi-channel lead to deliver electrical impulses from the IPG to the spine, and a mobile device application to enable individualized programming of the IPG. With a clinician programmer to allow for remote programming and monitoring of the patient via WIFI.

• Patient-Focused Integrated Solution
  With our patented SynerFuse® e-TLIF™ procedure we hope to help people live without pain by making traditional spine implant surgery more successful and cost effective by combining neuromodulation at the time surgeons are performing fusion back surgery.

• Surgeon-Centric
  Treat Neuropathic Pain at the Same Spinal Level as the Spine Surgery with single incision to maximize surgeon outcomes. Stim designed for surgeons.

• Fusion Hardware-Agnostic
  Add-on to any fusion hardware that surgeons prefer.

Strategic Partnership with Velentium Medical to support our build, design, and manufacturing of the NeuroFuse System.
Strategic partnership that brings together the necessary technical skills and technological innovations to enable SynerFuse® ULE Therapy.

Simulation of the e-TLIF™ Procedure that allows for ULE Therapy

Broad Patent Coverage to Enable Novel Innovation
SynerFuse® has 11 patents issued including the United States, Canada, and Australia. The SynerFuse® IP strategy protects key aspects of our concept and technology across the globe to enable our novel approach to solving chronic back pain.